A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with trastuzumab

被引：0
|
作者：
Storniolo, AM
Burris, HA
Overmoyer, B
Silverman, P
Pegram, MD
Jones, SF
Peacock, NW
Loftiss, J
Koch, KM
Paul, E
Ho, PTC
机构：
[1] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA
[2] Sarah Cannon Canc Ctr, Nashville, TN USA
[3] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA
[4] Univ Calif Los Angeles, Ctr Hlth Sci, Los Angeles, CA 90024 USA
[5] GSK, Res Triangle Pk, NC USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [41] An open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors
    Palshof, J. A.
    Kumler, I.
    Sorensen, P. G.
    Jensen, B. V.
    Nielsen, D. L.
    ANNALS OF ONCOLOGY, 2018, 29 : 142 - 142
  • [42] Pharmacokinetics, safety, and tolerability of sodium phenylacetate and sodium benzoate in healthy Japanese volunteers: A phase I, single-center, open-label study
    Endo, Fumio
    Nakamura, Kimitoshi
    Sano, Yuuhei
    Dote, Nobuhito
    Shimizu, Kohei
    Koumura, Emiko
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48
  • [43] Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Intravenous Siponimod: A Randomized, Open-label Study in Healthy Subjects
    Shakeri-Nejad, Kasra
    Gardin, Anne
    Gray, Cathy
    Neelakantham, Srikanth
    Dumitras, Swati
    Legangneux, Eric
    CLINICAL THERAPEUTICS, 2020, 42 (01) : 175 - 195
  • [44] Tolerability of riluzole in an open-label phase IIIb study
    Lacomblez, L
    Dib, M
    Doppler, V
    Faudet, A
    Robin, V
    Salachas, F
    Bensimon, G
    Meininger, V
    THERAPIE, 2002, 57 (01): : 65 - 71
  • [45] Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
    Galloway, Gantt P.
    Koch, Monika
    Cello, Ryan
    Smith, David E.
    BMC PSYCHIATRY, 2005, 5 (1)
  • [46] Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
    Gantt P Galloway
    Monika Koch
    Ryan Cello
    David E Smith
    BMC Psychiatry, 5
  • [47] SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY
    Uchino, Keita
    Komoda, Masato
    Tomomatsu, Junichi
    Okamoto, Takahiro
    Horiuchi, Kiyomi
    Tsuji, Akihito
    Ito, Yasuhiro
    Todo, Takuya
    Rito, Ki
    Takahashi, Shunji
    ENDOCRINE PRACTICE, 2017, 23 (02) : 149 - 156
  • [48] PHARMACOKINETICS AND TOLERABILITY OF ZONISAMIDE IN PAEDIATRIC PATIENTS WITH EPILEPSY: RESULTS OF A PHASE II, OPEN-LABEL STUDY
    Giorgi, L.
    Chouette, I.
    EPILEPSIA, 2012, 53 : 53 - 53
  • [49] Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study
    Bach, Thanh
    Galbiati, Shirley
    Kennedy, Jessie K.
    Deye, Gregory
    Nomicos, Effie Y. H.
    Codd, Ellen E.
    Garcia, Hector H.
    Horton, John
    Gilman, Robert H.
    Gonzalez, Armando E.
    Winokur, Patricia
    An, Guohua
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [50] Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase I, Open-Label Study
    Song, Ivy
    Suttle, Ben
    Wu, Jingyang
    Ilic, Katarina
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (06): : 645 - 654
12345